Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults
Status:
Terminated
Trial end date:
2019-02-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety and tolerability of
entospletinib (ENTO) monotherapy and in combination with chemotherapy in Japanese
participants.